188 related articles for article (PubMed ID: 17000721)
1. Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells.
Blanco LP; Dirita VJ
Infect Immun; 2006 Dec; 74(12):6957-64. PubMed ID: 17000721
[TBL] [Abstract][Full Text] [Related]
2. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system.
Blanco LP; DiRita VJ
Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
[TBL] [Abstract][Full Text] [Related]
4. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.
Winner L; Mack J; Weltzin R; Mekalanos JJ; Kraehenbuhl JP; Neutra MR
Infect Immun; 1991 Mar; 59(3):977-82. PubMed ID: 1705246
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin neutralization: a comparison of purified serum IgG and biliary secretory IgA antibodies.
Pierre P; Langendries A; Vaerman JP
Immunol Lett; 1988 May; 18(1):51-5. PubMed ID: 3378829
[TBL] [Abstract][Full Text] [Related]
6. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
[TBL] [Abstract][Full Text] [Related]
7. Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin.
Tamplin ML; Ahmed MK; Jalali R; Colwell RR
J Gen Microbiol; 1989 May; 135(5):1195-200. PubMed ID: 2482860
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.
Apter FM; Lencer WI; Finkelstein RA; Mekalanos JJ; Neutra MR
Infect Immun; 1993 Dec; 61(12):5271-8. PubMed ID: 7693598
[TBL] [Abstract][Full Text] [Related]
9. Free and complexed-secretory immunoglobulin A triggers distinct intestinal epithelial cell responses.
Salerno-Goncalves R; Safavie F; Fasano A; Sztein MB
Clin Exp Immunol; 2016 Sep; 185(3):338-47. PubMed ID: 27084834
[TBL] [Abstract][Full Text] [Related]
10. Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes.
Magnusson KE; Stjernström I
Immunology; 1982 Feb; 45(2):239-48. PubMed ID: 7037617
[TBL] [Abstract][Full Text] [Related]
11. Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.
Rochereau N; Drocourt D; Perouzel E; Pavot V; Redelinghuys P; Brown GD; Tiraby G; Roblin X; Verrier B; Genin C; Corthésy B; Paul S
PLoS Biol; 2013 Sep; 11(9):e1001658. PubMed ID: 24068891
[TBL] [Abstract][Full Text] [Related]
12. Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.
Richardson K; Kaper JB; Levine MM
Infect Immun; 1989 Feb; 57(2):495-501. PubMed ID: 2912896
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
15. Role of secretory antibodies in the defence against infections.
Brandtzaeg P
Int J Med Microbiol; 2003 Apr; 293(1):3-15. PubMed ID: 12755363
[TBL] [Abstract][Full Text] [Related]
16. Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation.
Murthy AK; Chaganty BK; Troutman T; Guentzel MN; Yu JJ; Ali SK; Lauriano CM; Chambers JP; Klose KE; Arulanandam BP
PLoS One; 2011 Feb; 6(2):e16847. PubMed ID: 21347387
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin A with protease activity secreted in human milk activates PAR-2 receptors, of intestinal epithelial cells HT-29, and promotes beta-defensin-2 expression.
Barrera GJ; Portillo R; Mijares A; Rocafull MA; del Castillo JR; Thomas LE
Immunol Lett; 2009 Mar; 123(1):52-9. PubMed ID: 19428552
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.
Uren TK; Wijburg OL; Simmons C; Johansen FE; Brandtzaeg P; Strugnell RA
Eur J Immunol; 2005 Jan; 35(1):180-8. PubMed ID: 15593123
[TBL] [Abstract][Full Text] [Related]
19. Unique characteristics of lacrimal glands as a part of mucosal immune network: high frequency of IgA-committed B-1 cells and NK1.1+ alphabeta T cells.
Saitoh-Inagawa W; Hiroi T; Yanagita M; Iijima H; Uchio E; Ohno S; Aoki K; Kiyono H
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):138-44. PubMed ID: 10634613
[TBL] [Abstract][Full Text] [Related]
20. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
